24. Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999).
J Am Vet Med Assoc 2001;218(4):543-546.
25. Robson DC, Burton GG. Cyclosporin: applications in small animal dermatology. Vet Dermatol 2003;14(1):1-10.
26. Padrid P. CVT update: feline asthma. In: Bonagura JD, ed. Kirk's current veterinary therapy XIII: small animal practice. Philadelphia: WB Saunders Co, 2000;805-810.
27. Mehl ML, Kyles AE, Craigmill AL, et al. Disposition of cyclosporine after intravenous and multi-dose oral administration
in cats. J Vet Pharmacol Ther 2003;26(5):349-354.
28. Schmiedt CW, Grimes JA, Holzman G, et al. Incidence and risk factors for development of malignant neoplasia after feline
renal transplantation and cyclosporine-based immunosuppression. Vet Comp Oncol 2009;7(1):45-53.
29. Zwerner J, Fiorentino D. Mycophenolate mofetil. Dermatol Ther 2007;20(4):229-238.
30. Villarroel MC, Hidalgo M, Jimeno A. Mycophenolate mofetil: An update. Drugs Today (Barc) 2009;45(7):521-532.
31. Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial
activity. Transpl Infect Dis 2009;11(4):290-297.
32. Nielsen L, Niessen S, Ramsay M, et al. The use of mycophenolate mofetil in eight dogs with idiopathic immune mediated haemolytic
anaemia [abstr], in Proceedings. Congress European Coll Vet Intern Med Companion Anim, 2005.
33. Yuki M, Sugimoto N, Otsuka H, et al. Recovery of a dog from aplastic anaemia after treatment with mycophenolate mofetil.
Aust Vet J 2007;85(12):495-497.
34. Dewey CW, Boothe DM, Rinn KL, et al. Treatment of a myasthenic dog with mycophenolate mofetil. J Vet Emerg Crit Care 2000;10:177-187.
35. Banyard MRC, Hassett RS. The use of mycophenolate mofetil in the treatment of a case of immune-mediated glomerulonephritis
in a dog. Aust Vet Pract 2001;31:103-106.
36. Dewey CW, Cerda-Gonzalez S, Fletcher DJ, et al. Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired
myasthenia gravis: 27 cases (1999-2008). J Am Vet Med Assoc 2010;236(6):664-668.
37. Lupu M, McCune JS, Kuhr CS, et al. Pharmacokinetics of oral mycophenolate mofetil in dog: bioavailability studies and the
impact of antibiotic therapy. Biol Blood Marrow Transplant 2006;12(12):1352-1354.
38. Chanda SM, Sellin JH, Torres CM, et al. Comparative gastrointestinal effects of mycophenolate mofetil capsules and enteric-coated
tablets of sodium-mycophenolic acid in beagle dogs. Transplant Proc 2002;34(8):3387-3392.
39. Marder W, McCune WJ. Advances in immunosuppressive therapy. Semin Respir Crit Care Med 2007;28(4):398-417.
40. Pinto P, Dougados M. Leflunomide in clinical practice. Acta Reumatol Port 2006;31(3):215-224.
41. Tallantyre E, Evangelou N, Constantinescu CS. Spotlight on teriflunomide. Int MS J 2008;15(2):62-68.
|
Featuring Information from:
